Primary |
Smoking Cessation Therapy |
62.3% |
Hypertension |
6.1% |
Depression |
5.1% |
Anxiety |
3.5% |
Pain |
3.3% |
Blood Cholesterol Increased |
2.5% |
Diabetes Mellitus |
2.2% |
Gastrooesophageal Reflux Disease |
1.6% |
Asthma |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.6% |
Sleep Disorder |
1.5% |
Bipolar Disorder |
1.4% |
Ex-smoker |
1.1% |
Ex-tobacco User |
1.0% |
Back Pain |
1.0% |
Insomnia |
0.9% |
Thyroid Disorder |
0.9% |
Hypersensitivity |
0.8% |
Arthritis |
0.8% |
Cardiac Disorder |
0.7% |
|
Nausea |
20.3% |
Vomiting |
10.1% |
Suicidal Ideation |
8.7% |
Depression |
6.2% |
Suicide Attempt |
5.7% |
Weight Increased |
5.2% |
Abnormal Dreams |
4.9% |
Insomnia |
4.6% |
Drug Ineffective |
4.5% |
Somnolence |
3.5% |
Weight Decreased |
3.4% |
Nightmare |
3.4% |
Anxiety |
3.3% |
Malaise |
2.8% |
Sleep Disorder |
2.8% |
Headache |
2.7% |
Rash |
2.3% |
Tremor |
2.1% |
Feeling Abnormal |
2.1% |
Nervousness |
1.7% |
|
Secondary |
Smoking Cessation Therapy |
42.7% |
Hypertension |
7.9% |
Depression |
7.6% |
Anxiety |
5.2% |
Pain |
5.1% |
Blood Cholesterol Increased |
4.1% |
Chronic Obstructive Pulmonary Disease |
3.5% |
Diabetes Mellitus |
3.2% |
Sleep Disorder |
2.9% |
Gastrooesophageal Reflux Disease |
2.4% |
Asthma |
2.3% |
Bipolar Disorder |
2.1% |
Back Pain |
1.7% |
Product Used For Unknown Indication |
1.6% |
Cardiac Disorder |
1.5% |
Drug Use For Unknown Indication |
1.4% |
Fibromyalgia |
1.3% |
Insomnia |
1.2% |
Arthritis |
1.2% |
Blood Pressure Abnormal |
1.2% |
|
Nausea |
13.9% |
Vomiting |
8.8% |
Abnormal Dreams |
8.5% |
Drug Ineffective |
7.0% |
Weight Increased |
6.4% |
Suicidal Ideation |
5.8% |
Depression |
5.7% |
Anxiety |
4.8% |
Insomnia |
4.4% |
Suicide Attempt |
3.9% |
Stress |
3.8% |
Weight Decreased |
3.7% |
Nightmare |
3.5% |
Somnolence |
3.3% |
Malaise |
3.2% |
Rash |
3.0% |
Nervousness |
2.9% |
Feeling Abnormal |
2.7% |
Sleep Disorder |
2.5% |
Headache |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
28.2% |
Drug Use For Unknown Indication |
19.0% |
Pain |
7.6% |
Smoking Cessation Therapy |
5.6% |
Depression |
5.1% |
Multiple Myeloma |
4.0% |
Ex-tobacco User |
3.5% |
Chronic Obstructive Pulmonary Disease |
3.4% |
Anxiety |
2.7% |
Hypertension |
2.6% |
Gastrooesophageal Reflux Disease |
2.3% |
Multiple Sclerosis |
2.1% |
Contraception |
2.0% |
Rheumatoid Arthritis |
2.0% |
Breast Cancer |
1.8% |
Osteoporosis |
1.7% |
Diabetes Mellitus |
1.7% |
Nausea |
1.6% |
Premenstrual Syndrome |
1.5% |
Asthma |
1.5% |
|
Weight Decreased |
18.1% |
Weight Increased |
10.4% |
Vomiting |
8.9% |
Pain |
7.3% |
Pulmonary Embolism |
6.9% |
Drug Ineffective |
5.3% |
Vision Blurred |
4.9% |
Tremor |
3.9% |
Myocardial Infarction |
3.7% |
Urinary Retention |
3.3% |
Deep Vein Thrombosis |
3.0% |
Dyspnoea |
3.0% |
Nausea |
3.0% |
Anxiety |
2.8% |
Wheezing |
2.8% |
Pain In Extremity |
2.6% |
Syncope |
2.6% |
Type 2 Diabetes Mellitus |
2.6% |
Product Quality Issue |
2.4% |
Pruritus |
2.2% |
|
Interacting |
Smoking Cessation Therapy |
25.3% |
Depression |
10.6% |
Hypertension |
7.6% |
Pain |
6.4% |
Convulsion |
6.3% |
Blood Cholesterol Increased |
4.8% |
Asthma |
4.5% |
Product Used For Unknown Indication |
4.3% |
Arthritis |
4.2% |
Anxiety |
3.9% |
Neuralgia |
2.6% |
Thyroid Disorder |
2.6% |
Pneumonia |
2.5% |
Sleep Disorder |
2.5% |
Bladder Disorder |
2.3% |
Mineral Supplementation |
2.2% |
Chronic Obstructive Pulmonary Disease |
2.0% |
Oral Candidiasis |
2.0% |
Dyspnoea |
1.8% |
Epilepsy |
1.8% |
|
Weight Increased |
27.4% |
Drug Interaction |
15.9% |
Vomiting |
7.0% |
Weight Decreased |
6.1% |
Suicidal Ideation |
5.4% |
Drug Ineffective |
3.5% |
Tobacco Withdrawal Symptoms |
3.5% |
Systemic Lupus Erythematosus |
3.2% |
Paranoia |
2.9% |
Somnolence |
2.9% |
Tremor |
2.9% |
Pain |
2.5% |
Homicidal Ideation |
2.2% |
Narcolepsy |
2.2% |
Neoplasm |
2.2% |
Nicotine Dependence |
2.2% |
Sleep Disorder |
2.2% |
Sleep Terror |
2.2% |
Insomnia |
1.9% |
Asthenia |
1.6% |
|